Austin, United States, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Surgical Staplers Market Size & Growth Analysis: According to SNS Insider, The Surgical Staplers Market was valued at USD 6.41 billion in 2025 and is projected to reach USD 10.87 billion by 2033, growing at a CAGR of 6.87% during the forecast period 2026-2033. The global burden of chronic diseases that require surgical intervention, rising surgical procedure volumes, and the growing acceptance of minimally invasive and laparoscopic surgeries are all f ...

国产手术机器人引领者，规模化出海启程 精锋医疗-B(2675) 精锋医疗首次覆盖报告 | [姓名table_Authors] | 电话 | 邮箱 | 登记编号 | [Table_Invest] 评级： | 增持 | | --- | --- | --- | --- | --- | --- | | 江珅(分析师) | 021-23185638 | jiangshen@gtht.com | S0880525090001 | | | | 赵峻峰(分析师) | 0755-23976629 | zhaojunfeng@gtht.com | S0880519080017 | [当前价格 Table_CurPrice] (港元)： | 58.80 | | 余文心(分析师) | 021-38676666 | yuwenxin@gtht.com | S0880525040111 | | | 本报告导读： 公司是国内手术机器人引领者，通过持续技术革新推动外科手术进步，全球临床手 术量快速爬升，伴随国内销量增长以及海外市场的商业化，公司收入获得快速增长。 投资要点： 风险提示。临床试验/临床评估不及预期风险；研发不及预期风险； 商业 ...

Key Takeaways ISRG delivered 20.5% revenue growth in 2025, with high-teens Q4 sales and procedures up 18% year over year.ISRG's growth was fueled by procedure volumes, rising utilization and da Vinci 5 placements.ISRG sees 13-15% procedure growth in 2026, aided by FDA clearance for cardiac uses of da Vinci 5.Intuitive Surgical (ISRG) delivered robust 2025 results, beating estimates on both counts. Total revenues rose 20.5% year over year to $10.1 billion. The company recorded adjusted earnings per share of ...

Back in October of last year, I initiated coverage on Intuitive Surgical, Inc. ( ISRG ). As stated back then, the company is at a very exciting intersection of robotics and healthcare. With this combination of futureI'm a full-time investor with a strong focus on the tech sector. I graduated with a Bachelor of Commerce Degree with Distinction, major in Finance. I'm also a proud lifetime member of the Beta Gamma Sigma International Business Honor Society. My core values are: Excellence, Integrity, Transparen ...

Atlassian公司股价下跌1.6%，Adobe公司股价下跌2.5%，Salesforce公司股价下跌2.7%，ServiceNow公司 股价下跌2.7%。云顶软件股价下跌3%，数据狗股价下跌2.2%，直觉外科股价下跌4.9%。 本文源自：金融界AI电报 ...

2月2日，国家药监局器械技术审评中心公示2026年第三批创新医疗器械特别审查申请审查结果，又有10款创新产品获准创新医疗器械特别审查程序。 以下本次进入创新通道的10款创新产品： 1.产品名称：慢性阻塞性肺部疾病辅助评估软件 申 请 人：波江生命科学（上海）有限公司 2.产品名称：超声治疗仪 申 请 人：深圳腾复医疗科技有限公司 3.产品名称：经导管人工三尖瓣瓣膜 申 请 人：爱德华兹生命科学有限责任公司 4.产品名称：经导管人工三尖瓣瓣膜 申 请 人：江苏臻亿医疗科技有限公司 5.产品名称：超声溶栓导管及支架系统 申 请 人：上海腾复医疗科技有限公司 6.产品名称：放射治疗计划软件 申 请 人：国科离子医疗科技有限公司 7.产品名称：植入式心律转复除颤器 申 请 人：创领心律管理医疗器械（上海）有限公司 8.产品名称：外周球扩覆膜支架系统 申 请 人：浙江归创医疗科技有限公司 9.产品名称：胸腹腔内窥镜手术系统 申 请 人：直观医疗公司 10.产品名称：冠状静脉窦球囊反搏系统 申 请 人：上海微创旋律医疗科技有限公司 本文为转载发布，仅做分享，文章中观点仅代表原平台作者观点，与本平台无关。如若本文有与贵平台 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30713 Intuitive Surgical, Inc. (Exact name of Registrant as specified in its Charter) (State or Other Jurisdiction ...

Market Performance - S&P 500 increased by 0.3% while Nasdaq decreased by 0.2% this week[1] - Small-cap stocks led the decline with Russell 2000 value down by 1.0% and Russell 2000 growth down by 3.1%[1] - Key sectors showing gains include telecommunications (+9.0%) and technology hardware (+4.6%) while software and services fell by 6.9%[1] Fund Flows - Estimated fund flow for S&P 500 components was -$84.1 million this week, a significant drop from +$5.6 million last week[2] - Major inflows were seen in technology hardware (+$40.3 million) and media and entertainment (+$39.5 million) while software and services experienced outflows of -$106.0 million[2] Earnings Forecast - S&P 500's forward 12-month EPS expectation increased by 0.8% this week, up from 0.2% last week[3] - Notable upward revisions were in technology hardware (+5.6%) and automotive (+3.2%) sectors, while energy saw a downward revision of -2.7%[3] Risk Factors - Economic fundamentals, international political uncertainties, U.S. fiscal policy, and Federal Reserve monetary policy present significant risks[3]

Market Performance - S&P 500 increased by 0.3% while Nasdaq decreased by 0.2% this week[1] - Small-cap stocks led the decline with Russell 2000 value down by 1.0% and Russell 2000 growth down by 3.1%[1] - 13 sectors saw gains, while 10 sectors experienced losses, with telecommunications leading at +9.0%[1] Fund Flows - Estimated fund flow for S&P 500 components was -$84.1 million this week, down from +$5.6 million last week[2] - Major inflows were seen in technology hardware (+$40.3 million) and media & entertainment (+$39.5 million)[2] - Significant outflows occurred in software & services (-$106.0 million) and healthcare equipment & services (-$57.7 million)[2] Earnings Forecast - S&P 500's forward 12-month EPS expectation increased by 0.8% this week, up from 0.2% last week[3] - 21 sectors had upward revisions, with technology hardware & equipment seeing the largest increase at +5.6%[3] - Energy sector saw a downward revision of -2.7%[3] Risks - Economic fundamentals, international political situations, U.S. fiscal policies, and Federal Reserve monetary policies present uncertainties[3]

Core Insights - Intuitive Surgical ended 2025 with strong earnings, placing 532 da Vinci surgical robots in Q4, a 7.9% increase from 493 in Q4 2024, with a total of 11,106 systems globally, reflecting a 12% year-over-year growth [1][5] Company Overview - Intuitive Surgical specializes in the da Vinci surgical robotic system, with robot sales contributing approximately 25% of total sales in 2025, consistent with 24% in 2024 [2] - The majority of revenue comes from services, instruments, and accessories, with instruments and accessories accounting for about 60% of overall sales, while services represent roughly 15% [3] Revenue Model - Approximately 75% of the company's revenue is recurring, driven by the need for maintenance and parts for the da Vinci systems, which creates a stable income stream that grows with each new unit installed [4] - In 2025, there was an 18% increase in procedures performed using the da Vinci system compared to 2024, indicating strong demand for surgical robots, with projected surgery growth of up to 15% in 2026 [5] Future Opportunities - The integration of artificial intelligence into products presents significant future growth opportunities, including a recently FDA-approved AI tool for real-time visual enhancements during lung biopsies [6] - The potential for AI to eventually perform surgeries autonomously is a long-term consideration for the company [6] Market Valuation - Intuitive Surgical's stock is currently trading at a price-to-earnings (P/E) ratio of nearly 67x, compared to the S&P 500's P/E ratio of 28x, indicating a premium valuation [7] - Historically, the company's average P/E over the past five years was nearly 72x, making the current valuation relatively more attractive, although still higher than the average growth stock's P/E of just under 40x [8] Investment Considerations - The company has significant growth potential in surgical robotics, but the stock is priced accordingly, suggesting that long-term holding may be necessary for investors to realize returns [9]